• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球呼吸疾病负担。

The global burden of respiratory disease.

机构信息

1 Department of Pediatrics, Cell Biology, and Physiology, Washington University in St. Louis, St. Louis, Missouri; and.

出版信息

Ann Am Thorac Soc. 2014 Mar;11(3):404-6. doi: 10.1513/AnnalsATS.201311-405PS.

DOI:10.1513/AnnalsATS.201311-405PS
PMID:24673696
Abstract

The Forum of International Respiratory Societies has released a report entitled Respiratory Disease in the World: Realities of Today-Opportunities for Tomorrow. The report identifies five conditions that primarily contribute to the global burden of respiratory disease (asthma, chronic obstructive pulmonary disease, acute respiratory infections, tuberculosis, and lung cancer), and offers an action plan to prevent and treat those diseases. It describes the staggering magnitude of the global burden of lung disease: hundreds of millions of people suffer and four million people die prematurely from respiratory diseases each year. The situation is not hopeless, because most major respiratory illnesses are avoidable. Much of the disease burden can be mitigated by reducing exposure to indoor and outdoor air pollution, restraining tobacco use, and relieving urban overcrowding. Implementation of the strategies described in the Forum of International Respiratory Societies respiratory diseases report would have a profound effect on respiratory health, reduce economic costs, and enhance health equality in the world.

摘要

国际呼吸学会联合会发布了一份题为《世界呼吸疾病:今日现实-明日机遇》的报告。报告确定了五种主要导致全球呼吸疾病负担的疾病(哮喘、慢性阻塞性肺疾病、急性呼吸道感染、结核病和肺癌),并提供了预防和治疗这些疾病的行动计划。报告描述了全球肺病负担的惊人规模:数以亿计的人患有肺病,每年有 400 万人因呼吸疾病而过早死亡。情况并非没有希望,因为大多数主要的呼吸道疾病都是可以预防的。通过减少室内和室外空气污染、限制烟草使用以及缓解城市过度拥挤,可以减轻大部分疾病负担。实施国际呼吸学会联合会呼吸疾病报告中描述的策略,将对呼吸健康产生深远影响,降低经济成本,并增强世界健康公平性。

相似文献

1
The global burden of respiratory disease.全球呼吸疾病负担。
Ann Am Thorac Soc. 2014 Mar;11(3):404-6. doi: 10.1513/AnnalsATS.201311-405PS.
2
The global burden of respiratory disease-impact on child health.呼吸系统疾病的全球负担——对儿童健康的影响
Pediatr Pulmonol. 2014 May;49(5):430-4. doi: 10.1002/ppul.23030. Epub 2014 Mar 9.
3
Lung disease in a global context. A call for public health action.全球范围内的肺部疾病。呼吁采取公共卫生行动。
Ann Am Thorac Soc. 2014 Mar;11(3):407-16. doi: 10.1513/AnnalsATS.201312-420PS.
4
Global Alliance against Chronic Respiratory Diseases.全球抗击慢性呼吸道疾病联盟
Eur Respir J. 2007 Feb;29(2):233-9. doi: 10.1183/09031936.00138606.
5
[Reducing the burden of chronic respiratory diseases].[减轻慢性呼吸道疾病负担]
Pneumonol Alergol Pol. 2009;77(1):3-4.
6
The environmental burden of disease in Canada: respiratory disease, cardiovascular disease, cancer, and congenital affliction.加拿大的疾病环境负担:呼吸系统疾病、心血管疾病、癌症和先天性疾病。
Environ Res. 2008 Feb;106(2):240-9. doi: 10.1016/j.envres.2007.08.009. Epub 2007 Sep 29.
7
[The environment and human respiratory system].[环境与人类呼吸系统]
Przegl Lek. 2008;65 Suppl 2:12-7.
8
Estimating the burden of disease attributable to indoor air pollution from household use of solid fuels in South Africa in 2000.估算2000年南非因家庭使用固体燃料造成室内空气污染所致的疾病负担。
S Afr Med J. 2007 Aug;97(8 Pt 2):764-71.
9
The burden of disease from indoor air pollution in developing countries: comparison of estimates.发展中国家室内空气污染导致的疾病负担:估计值比较
Int J Hyg Environ Health. 2003 Aug;206(4-5):279-89. doi: 10.1078/1438-4639-00224.
10
Global burden of acute respiratory infections in children: implications for interventions.儿童急性呼吸道感染的全球负担:对干预措施的影响。
Pediatr Pulmonol. 2003 Dec;36(6):469-74. doi: 10.1002/ppul.10344.

引用本文的文献

1
Evaluating the burden of respiratory tract infections among mortality cases in Karachi, Pakistan: a post-pandemic surveillance analysis.评估巴基斯坦卡拉奇死亡病例中呼吸道感染的负担:大流行后监测分析
J Glob Health. 2025 Aug 4;15:04198. doi: 10.7189/jogh.15.04198.
2
A computational framework for defining and validating reproducible phenotyping algorithms of 313 diseases in the UK Biobank.一种用于定义和验证英国生物银行中313种疾病的可重复表型分析算法的计算框架。
Sci Rep. 2025 Jul 9;15(1):24607. doi: 10.1038/s41598-025-05838-9.
3
Drug Delivery Systems for Respiratory Diseases: Insights into the Therapeutic Innovations for Pulmonary Administration.
用于呼吸系统疾病的药物递送系统:肺部给药治疗创新见解
Pharmaceutics. 2025 Apr 22;17(5):539. doi: 10.3390/pharmaceutics17050539.
4
Historical Trends and Risk Factors in Chronic Maxillary Sinusitis Among Dutch Pre-Adults (475-1866 CE).荷兰成年人前期(公元475 - 1866年)慢性上颌窦炎的历史趋势和风险因素
Am J Biol Anthropol. 2025 Apr;186(4):e70050. doi: 10.1002/ajpa.70050.
5
Association between vaccination, viral antibodies, and asthma prevalence in the U.S.: insights from NHANES (1999-2020).美国疫苗接种、病毒抗体与哮喘患病率之间的关联:来自美国国家健康与营养检查调查(1999 - 2020)的见解
Front Allergy. 2025 Mar 21;6:1456934. doi: 10.3389/falgy.2025.1456934. eCollection 2025.
6
The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases.肌醇在呼吸系统疾病患者管理中的治疗潜力。
Int J Mol Sci. 2025 Feb 28;26(5):2185. doi: 10.3390/ijms26052185.
7
Edge Computing System for Automatic Detection of Chronic Respiratory Diseases Using Audio Analysis.基于音频分析的慢性呼吸道疾病自动检测边缘计算系统
J Med Syst. 2025 Mar 4;49(1):33. doi: 10.1007/s10916-025-02154-7.
8
Impact of Hydrophobic, Hydrophilic, and Mucus-Binding Motifs on the Therapeutic Potential of Ceftazidime Analogs for Pulmonary Administration.疏水性、亲水性和黏液结合基序对头孢他啶类似物肺部给药治疗潜力的影响
Antibiotics (Basel). 2025 Feb 11;14(2):177. doi: 10.3390/antibiotics14020177.
9
Sustainable Nonwoven Scaffolds Engineered with Recycled Carbon Fiber for Enhanced Biocompatibility and Cell Interaction: From Waste to Health.采用回收碳纤维制造的可持续非织造支架,用于增强生物相容性和细胞相互作用:从废物到健康。
ACS Appl Bio Mater. 2025 Mar 17;8(3):1984-1996. doi: 10.1021/acsabm.4c01475. Epub 2025 Feb 17.
10
Financial burden of complications following lung resection: a scoping review protocol.肺切除术后并发症的经济负担:一项范围综述方案
BMJ Open. 2024 Dec 20;14(12):e083015. doi: 10.1136/bmjopen-2023-083015.